Orange SA’s talks to acquire Bouygues Telecom in France have been complicated by the number of parties involved but should be completed within weeks, according to a top Orange executive.
“We don’t want a deal in the air forever, it isn’t good for anyone,” Orange Deputy Chief Executive Officer Gervais Pellissier told Bloomberg Television on Monday in Barcelona, where he was attending Mobile World Congress. “Within a few weeks, we should be good with this.”
Orange, France’s former phone monopoly, is seeking to buy Bouygues Telecom in a transaction that could be valued at as much as 10 billion euros ($11 billion). The deal, which would reduce the number carriers in the country to three from four, is being scrutinized by regulators who are concerned with competition and the impact on consumers. Some of the discussions involve rivals Iliad SA and Numericable-SFR SAS who would purchase some assets of the combined company to address antitrust concerns.
“An argument between four people is always more difficult than between two people,” Pellissier said. “We want a deal that’s socially acceptable, and a deal that’s acceptable to antitrust authorities.”
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Judge Signals Revisions Likely in DOJ Case Targeting Live Nation Monopoly
Jan 22, 2025 by
CPI
American Airlines and JetBlue Agree to $2 Million Legal Fee Settlement with U.S. States
Jan 22, 2025 by
CPI
Federal Judge Dismisses Class Action Alleging Inflated Yacht Commission Fees
Jan 22, 2025 by
CPI
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan